Health products policy and standards

Our team provides authoritative guidance and standards on quality, safety and efficacy of health products and supports countries to formulate evidence-based policies and ensure good practice throughout the value chain.

About us

Highlights

A nurse accesses medicines in a cabinet at the National Hospital of Endocrinology in Hanoi, Vietnam.

Events

All →

7 – 11 October 2024

Fifty-eighth meeting of the WHO Expert Committee on Specifications for Pharmaceutical Preparations

Health Product Policy and Standards (HPS)

14 – 18 October 2024

Forty-seventh Expert Committee on Drug Dependence

22 – 25 October 2024

79th INN Consultation

22 October 2024 09:00 – 10:30 UTC Time

INN Session with INN stakeholders

News

All →

8 July 2024

News release

MeDevIS platform announced to boost access to medical technologies and devices

12 June 2024

Departmental update

WHO joins partners at ASEAN regional meeting to boost access to quality diagnostic testing

9 May 2024

Departmental update

Application period now open for the 2025 update of the WHO Model Lists of Essential Medicines

Calls for

All →

3 July 2024

Call for proposals

WHO Expert Committee on Drug Dependence (ECDD): Critical review report of coca leaf

16 June 2024

Call for consultation

Call for public consultation - Health technology assessment of medical devices, second edition

20 March 2024

Call for submissions

Call for submission - Submissions for the fifth WHO model list of essential in vitro diagnostics (EDL 5)

Expert Committees

Expert Committee on Selection and Use of Essential Medicines

Expert Committee on Biological Standardization

Expert Committee on Drug Dependence

Expert Committee on Specifications for Pharmaceutical Preparations (ECSPP)

Advisory groups

Advisory Group for Blood Regulation, Availability and Safety

Advisory Group of Experts on Assistive Technology

Strategic Advisory Group of Experts on In Vitro Diagnostics (SAGE IVD)

Strategic and Technical Advisory Group on Medical Devices (STAG MEDEV)

Technical Advisory Group on Pricing Policies for Medicines (TAG-PPM)

WHO Technical Advisory Group on the COVID-19 Technology Access Pool

Databases

Antibiotic characterization (AWaRe)

Assistive Technology Data Portal

ATC/DDD Index

International Pharmacopoeia

Model list of Essential Medicines

National Essential Medicines Lists

Model list of in Vitro Diagnostics

Priority Medical Devices Information System

ECDD Information repository

Publications

All →

WHO compendium of innovative health technologies for low-resource settings 2024

Access to appropriate, affordable, effective, and safe health technologies is paramount, especially in low-resource settings, where burden of non-communicable...

Download

The first issue of Volume 38, includesConsultation Documents:fluodeoxyglucose (18F) injection (fluodeoxyglucosi (18F) solution injectabilis)ATC/DDD ClassificationATC/DDD...

Download

Global strategy and plan of action on public health, innovation and intellectual property: implementation 2021-2023

Following a two-year negotiation process, the Sixty-first World Health Assembly adopted, in May 2008, resolution WHA61.21 on the global strategy and...

Download

Implementation of the Global strategy and plan of action on public health innovation and intellectual property: report on the Member States consultation 2023-2024

The Global Strategy and Plan of Action on Public Health, Innovation, and Intellectual Property (GSPA-PHI) was originally developed and approved by the...

Download